Logo image
Back
Time-dependent efficacy and safety of hypertonic saline versus mannitol in pediatric traumatic brain injury: a systematic review and meta-analysis
Journal article   Peer reviewed

Time-dependent efficacy and safety of hypertonic saline versus mannitol in pediatric traumatic brain injury: a systematic review and meta-analysis

Mohammed Alsabri, Shree Rath, Yahya A. Mahmoud, Abdalla M. Hadhoud, Eslam Abady, Ameer Hassoun and Eric Lusinski
Brain injury, v 40(7), pp 539-557
07 Jun 2026
DOI: https://doi.org/10.1080/02699052.2026.2634095
PMID: 41724523

Abstract

Life Sciences & Biomedicine Neurosciences Neurosciences & Neurology Rehabilitation Science & Technology
BackgroundTraumatic brain injury (TBI) represents a significant cause of morbidity and mortality in children, with secondary injuries such as elevated intracranial pressure (ICP) significantly impacting outcomes. Hyperosmolar therapy is a cornerstone of acute management, with hypertonic saline (HTS) and mannitol as principal agents; however, comparative evidence regarding their efficacy and safety in pediatric populations remains inconclusive.MethodsComprehensive searches of PubMed, Embase, and CENTRAL were performed up to June 2025. Primary outcomes were ICP reduction and all-cause mortality; secondary outcomes included neurological outcomes, adverse events, ICU/hospital stay, and physiological parameters. Meta-analyses employed random-effects models to pool risk ratios (RR), mean differences (MD), and proportions with 95% confidence intervals (CI).ResultsA total of 14 studies, including 680 pediatric patients with TBI, were analyzed. HTS was associated with an increase in serum sodium (mean change 5.47 mEq/L; 95% CI: 1.30-9.64), severe hypernatremia (37%; on resolving heterogeneity rose to 53%), acute kidney injury (2.1%), and acute respiratory distress syndrome (4.5%). Comparative meta-analysis revealed no significant difference in mortality between HTS and mannitol (RR = 0.78; 95% CI: 0.50-1.23) and similar survival rates (RR = 1.05; 95% CI: 0.96-1.14), with high certainty. The pooled mortality rate for HTS was 17% (95% CI: 11%-24%), and survival was 83% (95% CI: 76%-89%). Pooled HTS analyses demonstrated a time-dependent decrease in ICP: 17.35 mmHg at 30 minutes, 9.72 mmHg at 60 minutes, and 8.45 mmHg at 24 hours. No significant differences were found for cerebral perfusion pressure (CPP) at 24 hours, ICU stay, hospital stay, or mechanical ventilation duration.ConclusionIn pediatric TBI, hypertonic saline and mannitol provide comparable efficacy for ICP reduction and mortality, with HTS demonstrating rapid ICP lowering and manageable safety signals. While HTS is generally well tolerated, further high-quality multicenter RCTs with standardized protocols and long-term outcomes are needed to clarify its clinical advantages over mannitol.

Metrics

12 Record Views

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Neurosciences
Rehabilitation
Logo image